iBio, Fraunhofer USA Center for Molecular Biotechnology, U.S. Department of Defense deal

iBio granted the not-for-profit center a research license to use its iBioLaunch plant-based biomanufacturing technology for a combination vaccine to protect against anthrax and plague. The center is d...